Summary

Catheter Associated Urinary Tract Infections Treatment: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Catheter Associated Urinary Tract Infections Treatment offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Drug Type:

• Penicillin & Combinations
• Quinolones
• Cephalosporin
• Aminoglycoside Antibiotics
• Sulphonamides (Sulfamethoxazole +Trimethoprim)
• Azoles and Amphotericin B
• Tetracycline (Doxycycline)
• Nitrofurans (Nitrofurantoin)
• Other


By Indication Type:

• Asymptomatic CAUTI (Bacteriuria)
• Symptomatic CAUTI (Bacteremic)

By Distribution Channel:

• Hospital Pharmacies
• Gynaecology and Urology Clinics
• Drug Stores
• Retail Pharmacies
• Online Drug Stores


By Region:

• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• The Middle East & Africa (MEA)

Report Chapters

Executive Summary

The executive summary of the Catheter Associated Urinary Tract Infections Treatment includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Catheter Associated Urinary Tract Infections Treatment.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Catheter Associated Urinary Tract Infections Treatment in this chapter, which will help to understand basic information about Catheter Associated Urinary Tract Infections Treatment. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Catheter Associated Urinary Tract Infections Treatment report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Drug Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Catheter Associated Urinary Tract Infections Treatment Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 1.26 Billion) analysis (2018-2022) and current and future market value (USD 1.76 Billion) and volume (3.0% )projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Catheter Associated Urinary Tract Infections Treatment - Pricing Analysis

Based on By Drug Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033, By Drug Type

Based on By Drug Type, Catheter Associated Urinary Tract Infections Treatment is segmented into Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole +Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Other. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Type.

Chapter 06 - Global Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033, By Indication Type

Based on By Indication Type, Catheter Associated Urinary Tract Infections Treatment is segmented into Asymptomatic CAUTI (Bacteriuria), Symptomatic CAUTI (Bacteremic) . Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication Type.


Chapter 07 - Global Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Based on By Distribution Channel, Catheter Associated Urinary Tract Infections Treatment is segmented into Hospital Pharmacies, Gynaecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

Chapter 08 - Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Catheter Associated Urinary Tract Infections Treatment is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Catheter Associated Urinary Tract Infections Treatment in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Catheter Associated Urinary Tract Infections Treatment in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Catheter Associated Urinary Tract Infections Treatment in the Latin America region.

Chapter 11 - Europe Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Catheter Associated Urinary Tract Infections Treatment in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Catheter Associated Urinary Tract Infections Treatment in the regional market.

Chapter 12 - East Asia Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Catheter Associated Urinary Tract Infections Treatment in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Catheter Associated Urinary Tract Infections Treatment in the regional market.

Chapter 13 - South Asia Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Catheter Associated Urinary Tract Infections Treatment in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Catheter Associated Urinary Tract Infections Treatment in the regional market.

Chapter 14 - Middle East and Africa Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Catheter Associated Urinary Tract Infections Treatment in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Catheter Associated Urinary Tract Infections Treatment in the regional market.

Chapter 15 - Key Countries Catheter Associated Urinary Tract Infections Treatment Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Catheter Associated Urinary Tract Infections Treatment is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Drug Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Pfizer Inc.; Merck & Co., Inc.; GlaxoSmithKline (GSK); AstraZeneca; Bayer AG; Johnson & Johnson; Novartis International AG; Sanofi; Roche Holding AG; Eli Lilly and Company; Bristol-Myers Squibb Company; Abbott Laboratories; Astellas Pharma Inc.; Boehringer Ingelheim; Daiichi Sankyo Company, Limited; Gilead Sciences, Inc.; Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Lupin Limited

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Catheter Associated Urinary Tract Infections Treatment report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Catheter Associated Urinary Tract Infections Treatment.

ページTOPに戻る

Table of Contents

1. Executive Summary
2. Market Overview
3. Key Market Trends
4. Value Added Insights
5. Market Background
6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Drug Type
7.1. Penicillin & Combinations
7.1.1. Amoxicillin
7.1.2. Amoxicillin+ Clavulanate Potassium
7.1.3. Others
7.2. Quinolones
7.2.1. Ciprofloxacin
7.2.2. Levofloxacin
7.2.3. Nalidixic Acid
7.2.4. Norfloxacin
7.2.5. Others
7.3. Cephalosporin
7.3.1. Ceftriaxone
7.3.2. Cefuroxime
7.3.3. Cefixime
7.3.4. Cephalexin
7.4. Aminoglycoside Antibiotics
7.4.1. Amikacin
7.4.2. Gentamicin
7.5. Sulphonamides (Sulfamethoxazole + Trimethoprim)
7.6. Azoles and Amphotericin B
7.7. Tetracycline (Doxycycline)
7.8. Nitrofurans (Nitrofurantoin)
7.9. Other
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
8.1. Asymptomatic CAUTI (Bacteriuria)
8.2. Symptomatic CAUTI (Bacteremic)
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
9.1. Hospital Pharmacies
9.2. Gynecology and Urology Clinics
9.3. Drug Stores
9.4. Retail Pharmacies
9.5. Online Drug Stores
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
10.1. North America
10.2. Latin America
10.3. Europe
10.4. East Asia
10.5. South Asia
10.6. Oceania
10.7. Middle East and Africa (MEA)
11. North America Analysis 2017 to 2022 and Forecast 2023 to 2033
12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14. East Asia Analysis 2017 to 2022 and Forecast 2023 to 2033
15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16. Oceania Market 2017 to 2022 and Forecast 2023-2033
17. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18. Market Structure Analysis
19. Competition Analysis
19.1. Pfizer
19.2. Merck & Co., Inc.
19.3. GlaxoSmithKline (GSK)
19.4. AstraZeneca
19.5. Bayer AG
19.6. Johnson & Johnson
19.7. Novartis International AG
19.8. Sanofi
19.9. Roche Holding AG
19.10. Eli Lilly and Company
19.11. Bristol-Myers Squibb Company
19.12. Abbott Laboratories
19.13. Astellas Pharma Inc.
19.14. Boehringer Ingelheim
19.15. Daiichi Sankyo Company, Limited
19.16. Gilead Sciences, Inc.
19.17. Mylan N.V.
19.18. Teva Pharmaceutical Industries Ltd.
19.19. Sun Pharmaceutical Industries Ltd.
19.20. Lupin Limited
20. Assumptions and Acronyms Used
21. Research Methodology